1065 Results of a multimodality preoperative induction treatment program in locally advanced (LAD) NSCLC stages IIIA and IIIB
Wilfried Eberhardt(National Center for Tumor Diseases), S. Seeber, A. Haarstrick(Essen University Hospital), H. Menker(Essen University Hospital), Michael Ståhl(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), L. Schlenger(Charité - Universitätsmedizin Berlin), H. Wilke(Kliniken Essen-Mitte), U. Fuths(Essen University Hospital), Martin Stuschke(Essen University Hospital), D. Greshuchna(Essen University Hospital), Mark Müller, U. Klaassen(West German Heart and Vascular Center Essen), Georgios Stamatis(Ruhrlandklinik), Volker Budach(Humboldt-Universität zu Berlin), M. R. Nowrousian(Essen University Hospital), N Konietzko
Cited by 1
Related Papers
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial
|The Lancet|2009|1.4k
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
|New England Journal of Medicine|2015|1k
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
|Journal of Clinical Oncology|2017|872